De novo Design of SARS-CoV-2 Main Protease Inhibitors

被引：8

作者：

Fischer, Christian ^{[1
]}

Veprek, Nynke A. ^{[1
,2
]}

Peitsinis, Zisis ^{[1
]}

Ruhmann, Klaus-Peter ^{[1
]}

Yang, Chao ^{[1
]}

Spradlin, Jessica N. ^{[3
]}

Dovala, Dustin ^{[4
]}

Nomura, Daniel K. ^{[3
]}

Zhang, Yingkai ^{[1
]}

Trauner, Dirk ^{[1
]}

机构：

[1] NYU, Dept Chem, 100 Washington Sq East, New York, NY 10003 USA

[2] Ludwig Maximilians Univ Munchen, Dept Chem, Butenandtstr 5-13, D-81377 Munich, Germany

[3] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA

[4] Novartis Inst BioMed Res, Emeryville, CA 94608 USA

来源：

SYNLETT | 2022年 / 33卷 / 05期

基金：

美国国家卫生研究院; 瑞士国家科学基金会;

关键词：

viral main protease; small-molecule inhibitor; SARS-CoV-2; coronavirus; molecular modeling;

D O I：

10.1055/a-1582-0243

中图分类号：

O62 [有机化学];

学科分类号：

070303 ; 081704 ;

摘要：

The COVID-19 pandemic prompted many scientists to investigate remedies against SARS-CoV-2 and related viruses that are likely to appear in the future. As the main protease of the virus, M-Pro , is highly conserved among coronaviruses, it has emerged as a prime target for developing inhibitors. Using a combination of virtual screening and molecular modeling, we identified small molecules that were easily accessible and could be quickly diversified. Biochemical assays confirmed a class of pyridones as low micromolar noncovalent inhibitors of the viral main protease.

引用

页码：458 / 463

页数：6

共 50 条

[31] Plant protease inhibitors against SARS-CoV-2 main protease: an in silico approach
Lima, Adrianne M.
de Souza, Adson A.
Amaral, Jackson L.
Freire, Valder N.
Souza, Pedro F.
de Oliveira, Hermogenes D.
FUTURE VIROLOGY, 2023, 18 (07) : 439 - 454
[32] Computational studies on the design of NCI natural products as inhibitors to SARS-CoV-2 main protease
Durgam, Laxman
Guruprasad, Lalitha
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (09): : 3741 - 3751
[33] Statine-based peptidomimetic compounds as inhibitors for SARS-CoV-2 main protease (SARS-CoV-2 Mpro)
Azevedo, Pedro Henrique R. de A.
Camargo, Priscila G.
Constant, Larissa E. C.
Costa, Stephany da S.
Silva, Celimar Sinezia
Rosa, Alice S.
Souza, Daniel D. C.
Tucci, Amanda R.
Ferreira, Vivian N. S.
Oliveira, Thamara Kelcya F.
Borba, Nathalia R. R.
Rodrigues, Carlos R.
Albuquerque, Magaly G.
Dias, Luiza R. S.
Garrett, Rafael
Miranda, Milene D.
Allonso, Diego
Lima, Camilo Henrique da S.
Muri, Estela Maris F.
SCIENTIFIC REPORTS, 2024, 14 (01):
[34] SARS-CoV-2 Main Protease as Target
不详
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (06) : 1278 - 1278
[35] Repurposing of renin inhibitors as SARS-COV-2 main protease inhibitors: A computational study
Refaey, Rana H.
El-Ashrey, Mohamed K.
Nissan, Yassin M.
VIROLOGY, 2021, 554 : 48 - 54
[36] Potential Self-Peptide Inhibitors of the SARS-CoV-2 Main Protease
Banerjee, Arkadeep
Gosavi, Shachi
JOURNAL OF PHYSICAL CHEMISTRY B, 2023, 127 (04): : 855 - 865
[37] Triterpenic Acid Amides as Potential Inhibitors of the SARS-CoV-2 Main Protease
Baev, Dmitry S.
Blokhin, Mikhail E.
Chirkova, Varvara Yu.
Belenkaya, Svetlana V.
Luzina, Olga A.
Yarovaya, Olga I.
Salakhutdinov, Nariman F.
Shcherbakov, Dmitry N.
MOLECULES, 2023, 28 (01):
[38] Azapeptides with unique covalent warheads as SARS-CoV-2 main protease inhibitors
Khatua, Kaustav
Alugubelli, Yugendar R.
Yang, Kai S.
Vulupala, Veerabhadra R.
Blankenship, Lauren R.
Coleman, Demonta
Atla, Sandeep
Chaki, Sankar P.
Geng, Zhi Zachary
Xiao, Jing
Chen, Peng-Hsun
Cho, Chia-Chuan D.
Sharma, Shivangi
Vatansever, Erol C.
Ma, Yuying
Yu, Ge
Neuman, Benjamin W.
Xu, Shiqing
Liu, Wenshe Ray
ANTIVIRAL RESEARCH, 2024, 225
[39] Search of Novel Small Molecule Inhibitors for the Main Protease of SARS-CoV-2
Zhang, Wenfa
Lin, Sheng-Xiang
VIRUSES-BASEL, 2023, 15 (02):
[40] Molecular Docking Unveils Prospective Inhibitors for the SARS-COV-2 Main Protease
Ahmad, Fawad
Ikram, Saima
Ahmad, Jamshaid
Rehman, Irshad Ur
Khattak, Saeed Ullah
Butt, Sadia
Mushtaq, Maryam
SAINS MALAYSIANA, 2021, 50 (05): : 1473 - 1484

← 1 2 3 4 5 →